H.C. Wainwright Reaffirms Their Buy Rating on Urogen Pharma (URGN)
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Urogen Pharma (URGN – Research Report) today and set a price target of $2...
Source: businessinsider.com